HP
Hikari Power Portfolio holdings
AUM
$1.2B
This Quarter Return
-2.57%
1 Year Return
+14.18%
3 Year Return
+56.59%
5 Year Return
+122.08%
10 Year Return
+191.59%
AUM
$1.16B
AUM Growth
+$1.16B
(-3.8%)
Cap. Flow
-$6.56M
Cap. Flow
% of AUM
-0.57%
Top 10 Holdings %
Top 10 Hldgs %
76.65%
Holding
62
New
–
Increased
1
Reduced
2
Closed
3
Top Buys
| 1 |
Vanguard Health Care ETF
VHT
|
$63.4K |
Top Sells
| 1 |
Boeing
BA
|
$3.73M |
| 2 |
US Bancorp
USB
|
$242K |
| 3 |
Fortive
FTV
|
$67.5K |
Sector Composition
| 1 | Financials | 56.59% |
| 2 | Healthcare | 16.39% |
| 3 | Materials | 7.23% |
| 4 | Energy | 6.5% |
| 5 | Technology | 4.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Medtronic
MDT
$118B
| $6.32M | 0.55% |
79,060
| – | – |
|
27
Veralto
VLTO
$26.1B
| $5.46M | 0.47% |
53,606
| – | – |
|
28
Becton Dickinson
BDX
$54.3B
| $5.44M | 0.47% |
23,970
| – | – |
|
29
Mastercard
MA
$536B
| $5.27M | 0.45% |
10,000
| – | – |
|
|
30
Fortive
FTV
$15.9B
| $4.85M | 0.42% |
64,700
-900
| -1% | -$67.5K |
|
31
Honeywell
HON
$136B
| $3.66M | 0.32% |
16,200
| – | – |
|
32
Lockheed Martin
LMT
$105B
| $3.57M | 0.31% |
7,340
| – | – |
|
33
Berkshire Hathaway Class B
BRK.B
$1.08T
| $3.48M | 0.3% |
7,670
| – | – |
|
34
Jack Henry & Associates
JKHY
$11.8B
| $3.34M | 0.29% |
19,070
| – | – |
|
35
Ametek
AME
$42.6B
| $3.13M | 0.27% |
17,380
| – | – |
|
36
Coca-Cola
KO
$297B
| $3.01M | 0.26% |
48,400
| – | – |
|
37
Vanguard FTSE Emerging Markets ETF
VWO
$96.5B
| $2.59M | 0.22% |
58,810
| – | – |
|
38
3M
MMM
$81B
| $2.43M | 0.21% |
18,790
| – | – |
|
|
39
Vanguard Health Care ETF
VHT
$15.5B
| $2.28M | 0.2% |
8,990
+250
| +3% | +$63.4K |
|
40
Merck
MRK
$210B
| $2.26M | 0.2% |
22,710
| – | – |
|
41
Alphabet (Google) Class A
GOOGL
$2.79T
| $2.23M | 0.19% |
11,780
| – | – |
|
42
Vontier
VNT
$6.24B
| $2.07M | 0.18% |
56,786
| – | – |
|
43
Parker-Hannifin
PH
$94.8B
| $1.81M | 0.16% |
2,840
| – | – |
|
44
Bank of America
BAC
$371B
| $1.77M | 0.15% |
40,240
| – | – |
|
45
Gilead Sciences
GILD
$140B
| $1.72M | 0.15% |
18,630
| – | – |
|
46
Bristol-Myers Squibb
BMY
$96.7B
| $1.69M | 0.15% |
29,820
| – | – |
|
47
Union Pacific
UNP
$132B
| $930K | 0.08% |
4,080
| – | – |
|
48
Anavex Life Sciences
AVXL
$817M
| $919K | 0.08% |
85,585
| – | – |
|
49
Ecolab
ECL
$77.5B
| $869K | 0.08% |
3,710
| – | – |
|
50
MetLife
MET
$53.6B
| $866K | 0.07% |
10,580
| – | – |
|